WHO ICTRP trial
scalp alopecia areata treatment
IRCT201410113566N5 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT201410113566N5 |
|---|---|
| Public title | scalp alopecia areata treatment |
| Scientific title | Comprative Efficiacy of Diphenylcyclopropenone vs Anthralin in Patients with Alopecia Areata |
| Primary sponsor | Tabriz University of Medical Sciences, assistance research |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of) |
| Conditions | Alopecia areata. Alopecia areata;Alopecia areata |
| Interventions | Intervention 1: Topical Diphenylcyclopropenone weekly up to three months (once per week). Intervention 2: Topical Anthralin daily up to three months (once per day).;Treatment - Drugs;Treatment - Drugs;Topical Diphenylcyclopropenone weekly… |
| Registration date | Oct 23, 2014 |
| Target size | 50 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: